Joshua Copp

Joshua Copp currently serves as Chief Business Officer at Ceribell, focusing on point-of-care EEG solutions since October 2023. Prior to this role, Joshua Copp accumulated extensive experience at McKinsey & Company over an eleven-year period, ascending through positions from Associate to Partner, specializing in various management consulting functions. Additional experience includes a role as a Teaching Assistant at MIT Sloan School of Management and a Summer Associate position with McKinsey & Company in the pharmaceutical and medical products strategy sector. Earlier in the career, Joshua Copp worked as an Analyst at Boston Consulting Group, developing advanced valuation techniques for M&A and corporate strategy. Joshua Copp holds an MBA with a focus on Finance and Healthcare from MIT Sloan School of Management and an AB in Applied Mathematics from Harvard University.